Sugi Predict

Sugi Predict / Compounds / SCHEMBL18907708

SCHEMBL18907708

SCHEMBL18907708

CC(C)O[C@@H](CO)c1cc(F)ccc1OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC6A9 P48067 1/20 0.42
▸ SLC6A5 Q9Y345 1/20 0.42
▸ MRGPRX4 Q96LA9 2/20 0.42
▸ LRRK2 Q5S007 2/20 0.41
▸ LIPE Q05469 1/20 0.40
▸ L3MBTL1 Q9Y468 4/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ FFAR1 O14842 2/20 0.39
▸ FFAR4 Q5NUL3 2/20 0.39
▸ PTGER1 P34995 2/20 0.38
▸ PTGER4 P35408 1/20 0.38
▸ PTGER3 P43115 1/20 0.38
▸ PTGER2 P43116 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ ABCB1 P08183 1/20 0.38
▸ C5AR1 P21730 1/20 0.38
▸ CCR5 P51681 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907703 1.00 SLC6A9 (0.42) SLC6A9SLC6A5MRGPRX4LRRK2LIPE
SCHEMBL18821424 0.82 SLC6A9 (0.42) SLC6A9SLC6A5MRGPRX4LRRK2LIPE
SCHEMBL18796914 0.82 SLC6A9 (0.42) SLC6A9SLC6A5MRGPRX4LRRK2LIPE
SCHEMBL18907710 0.81 SLC6A9 (0.42) SLC6A9SLC6A5MRGPRX4LRRK2L3MBTL1
SCHEMBL17868304 0.80 HTR2A (0.38) MAPK1
SCHEMBL18914274 0.80 HTR2A (0.38) MAPK1
SCHEMBL18907693 0.80 FAAH (0.38) L3MBTL1TDP1
SCHEMBL18907694 0.80 FAAH (0.38) L3MBTL1TDP1
SCHEMBL19361580 0.80 KCNH2 (0.34) L3MBTL1TDP1
SCHEMBL17040781 0.79 SLC6A9 (0.49) SLC6A9SLC6A5MRGPRX4LIPEL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912718-B2 Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof GILEAD APOLLO, LLC (US) 2024-02-27 — — US disclosed
US-11912718-B2 Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof GILEAD APOLLO, LLC (US) 2024-02-27 — — US disclosed
US-10800791-B2 Triazole ACC inhibitors and uses thereof GILEAD APOLLO, LLC (US) 2020-10-13 — — US disclosed
US-20200148699-A1 SOLID FORMS OF A THIENOPYRIMIDINEDIONE ACC INHIBITOR AND METHODS FOR PRODUCTION THEREOF GILEAD APOLLO, LLC 2020-05-14 — — US disclosed
US-20190241582-A1 Triazole ACC inhibitors and uses thereof Nimbus Apollo, Inc. 2019-08-08 — — US disclosed
US-20190225623-A1 SOLID FORMS OF A THIENOPYRIMIDINEDIONE ACC INHIBITOR AND METHODS FOR PRODUCTION THEREOF NIMBUS DISCOVERY, INC. 2019-07-25 — — US disclosed
US-10183951-B2 Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof GILEAD APOLLO, LLC (US) 2019-01-22 — — US disclosed
US-20170267690-A1 SOLID FORMS OF A THIENOPYRIMIDINEDIONE ACC INHIBITOR AND METHODS FOR PRODUCTION THEREOF J.P. LAWSON CONSULTING LLC 2017-09-21 — — US disclosed
US-20170267690-A1 SOLID FORMS OF A THIENOPYRIMIDINEDIONE ACC INHIBITOR AND METHODS FOR PRODUCTION THEREOF J.P. LAWSON CONSULTING LLC 2017-09-21 — — US disclosed
US-20170166584-A1 TRIAZOLE ACC INHIBITORS AND USES THEREOF Nimbus Apollo, Inc. 2017-06-15 — — US disclosed
WO-2017091617-A1 TRIAZOLE ACC INHIBITORS AND USES THEREOF GILEAD APOLLO, LLC (US) 2017-06-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170267690-A1 SOLID FORMS OF A THIENOPYRIMIDINEDIONE ACC INHIBITOR AND METHODS FOR PRODUCTION THEREOF ACACA, ACACB, COASY SLC6A9 4188/4885SLC6A5 3745/4885MRGPRX4 4837/4885
US-11912718-B2 Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof ACACA, ACACB, COASY SLC6A9 4188/4885SLC6A5 3745/4885MRGPRX4 4837/4885
US-20200148699-A1 SOLID FORMS OF A THIENOPYRIMIDINEDIONE ACC INHIBITOR AND METHODS FOR PRODUCTION THEREOF ACACA, ACACB, COASY SLC6A9 4188/4885SLC6A5 3745/4885MRGPRX4 4837/4885
US-20190241582-A1 Triazole ACC inhibitors and uses thereof ACACA, ACACB, ACAT1 SLC6A9 3707/4885SLC6A5 3214/4885MRGPRX4 4718/4885
US-10183951-B2 Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof ACACA, ACACB, COASY SLC6A9 4188/4885SLC6A5 3745/4885MRGPRX4 4837/4885
US-20190225623-A1 SOLID FORMS OF A THIENOPYRIMIDINEDIONE ACC INHIBITOR AND METHODS FOR PRODUCTION THEREOF ACACA, ACACB, COASY SLC6A9 4188/4885SLC6A5 3745/4885MRGPRX4 4837/4885
US-10800791-B2 Triazole ACC inhibitors and uses thereof ACACA, ACACB, ACAT1 SLC6A9 3707/4885SLC6A5 3214/4885MRGPRX4 4718/4885
US-20170166584-A1 TRIAZOLE ACC INHIBITORS AND USES THEREOF ACACA, ACACB, ACAT1 SLC6A9 3707/4885SLC6A5 3214/4885MRGPRX4 4718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.